Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet STUGERON 25mg tablets
- Product code:
- W10590001
- Quantity:
- 40
- Indicated for:
- vertigo; vestibular disorders
- Route of administration:
- oral
- Substance:
- cinnarizine (antihistamine)
- ATC
- N07CA02 — Nervous system | Antivertigo preparations
Precautions:
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
Cinnarizine is a medication used to treat balance disorders and associated symptoms such as dizziness, vertigo, nausea, and vomiting. It is commonly prescribed for vestibular conditions such as Ménière's disease, vertigo of peripheral or central origin, and cerebral circulatory disorders.
Cinnarizine acts as a calcium channel antagonist, reducing calcium influx into smooth muscle cells of blood vessels. This mechanism improves blood circulation, particularly in the inner ear and brain, reducing vestibular overstimulation and associated symptoms.
It is also used for the prevention of motion sickness, effectively reducing nausea and dizziness caused by travel. Additionally, it may be prescribed to alleviate symptoms caused by peripheral vascular disorders, such as Raynaud's syndrome.
Side effects may include drowsiness, fatigue, dry mouth, headache, or gastrointestinal disturbances. In rare cases, allergic reactions, tremors, or muscle stiffness may occur, especially in elderly patients. Patients should avoid alcohol or other sedatives during treatment, as these may enhance drowsiness.
Patients should strictly follow their doctor’s instructions regarding dosage and treatment duration. It is advised not to drive or operate heavy machinery while using this medication due to the risk of drowsiness.
Cinnarizine acts as a calcium channel antagonist, reducing calcium influx into smooth muscle cells of blood vessels. This mechanism improves blood circulation, particularly in the inner ear and brain, reducing vestibular overstimulation and associated symptoms.
It is also used for the prevention of motion sickness, effectively reducing nausea and dizziness caused by travel. Additionally, it may be prescribed to alleviate symptoms caused by peripheral vascular disorders, such as Raynaud's syndrome.
Side effects may include drowsiness, fatigue, dry mouth, headache, or gastrointestinal disturbances. In rare cases, allergic reactions, tremors, or muscle stiffness may occur, especially in elderly patients. Patients should avoid alcohol or other sedatives during treatment, as these may enhance drowsiness.
Patients should strictly follow their doctor’s instructions regarding dosage and treatment duration. It is advised not to drive or operate heavy machinery while using this medication due to the risk of drowsiness.
General data about STUGERON 25mg
- Substance:
- cinnarizine
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W10590001
- Concentration:
- 25mg
- Pharmaceutical form:
- tablets
- Quantity:
- 40
- Product type:
- Original
- Price:
- 9.52 RON
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for cinnarizine
- 25mg
- 75mg
Combinations with other substances
Compensation lists for STUGERON 25mg Terapia
C3 - Sublist C - section C3 (children, pregnant women and postpartum women) with 100% discount from the reference price
- Price
- 9.52 RON
- Copayment
- 9.52 RON
- Patient
- 0.00 RON